REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
18/05/2026
Voltar para busca
Dado oficial do USPTO
LINNEA 315CSE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LINNEA 315CSE
ST13
US500000088589105Classe
1, 5
Pedido
88589105
Registro
6351234
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
19/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
22/08/2019
Data de registro
18/05/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/05/2021
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Riazzino, CH
Examinador
JOHNSON, AISHA CLARKE
Localização atual
Historical data usage
Titulares e representantes
Titulares
LINNEA SA
Representantes
Perla M. Kuhn FOX ROTHSCHILD LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical additives for use in the manufacture of pharmaceuticals; botanical extractsactive substances and active chemical ingredients for use in the manufacture of pharmaceuticals; botanical extractsactive substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system; botanical extractsactive substances and active chemical ingredients for use in the manufacture of veterinary preparations; plant extractsactive compounds and active chemical ingredients for use in the manufacture of pharmaceuticals; plant extractsactive substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system; chemicals for use in the manufacture of cosmetics and food; botanical extracts for use in the manufacture of cosmetics and food; botanical extracts for use in the manufacture of cosmetics and dietary supplements; food preserving chemicals; plant extractsactive substances and active chemical ingredients for use in the manufacture of cosmetics and dietary supplements
Classe 5
Pharmaceuticals derived from botanical and plant extracts; pharmaceuticals derived from botanical and plant extracts for veterinary purposes; pharmaceuticals derived from botanical and plant extracts for use in the treatment of skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system; medicines for veterinary purposes; dietary supplements based on botanical and plant extracts; dietary supplements based on botanical and plant extracts for pharmaceutical and veterinary purposes; dietary supplements based on botanical and plant extracts in the form of pharmaceuticals for treating skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system; plant extractsactive substances and active chemical ingredients for veterinary use; plant extractsactive substances and active chemical ingredients for use in the pharmaceutical industry; plant extractsactive substances and active chemical ingredients for use in the cosmetics industry; chemical preparations for pharmaceutical or medical purposesfor use in the treatment of skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
29/04/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
26/09/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
23/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
06/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
18/05/2021
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
09/04/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/04/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
20/01/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
20/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/07/2020
PUBO
PUBLISHED FOR OPPOSITION
21/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2020
ALIE
ASSIGNED TO LIE
11/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/12/2019
GNRT
NON-FINAL ACTION E-MAILED
04/12/2019
CNRT
NON-FINAL ACTION WRITTEN
04/12/2019
DOCK
ASSIGNED TO EXAMINER
21/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2019
NWAP
NEW APPLICATION ENTERED
26/08/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LINNEA 315CSE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.